The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression.

Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression.

Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.

Author: Bita Moghaddam
Series: The MIT Press Essential Knowledge
Publisher: The MIT Press
Page Count: 208pp
Size: 5 x 7
Notes: paperback
Date of Publication: February 16, 2021
ISBN: 978-0262542241